View Cart (0 items)

Johnson & Johnson to eliminate 900 positions, mostly sales

April 13, 2009
/ Print / Reprints /
| Share More
/ Text Size+
Diversified healthcare company Johnson & Johnson announced it was eliminating 900 positions from its Ortho-McNeil-Janssen Pharmaceutical unit in the latest downsizing move in the drug industry, according to Reuters. The reductions occurred across Ortho-McNeil-Janssen, but the majority of the jobs impacted were from sales, spokeswoman Kara Russell said. Russell said attrition and hiring freezes were involved in the overall reduction, but she declined to say just how many people were losing their jobs. J&J owns more than 250 operating companies and employs about 119,000 people worldwide. Ortho-McNeil-Janssen is one legal entity that includes several divisions. Virtually all of the major pharmaceutical companies have announced significant job cuts over the past couple of years as lucrative drugs lose patent protection and few important new medicines reach the market to replace them. Sales forces have often been at the forefront of the cuts as competition from cheap generic medicines take their toll and with doctors looking to spend less time with drug company representatives.
You must login or register in order to post a comment.

Related Events